 Corrella Detweiler
Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella typhimurium | 22 | 2022 | 165 | 6.440 |
Why?
| | Macrophages | 22 | 2023 | 1259 | 4.800 |
Why?
| | Anti-Bacterial Agents | 11 | 2023 | 1471 | 3.040 |
Why?
| | Salmonella Infections | 8 | 2022 | 50 | 2.670 |
Why?
| | Salmonella enterica | 6 | 2020 | 51 | 2.180 |
Why?
| | Salmonella Infections, Animal | 8 | 2019 | 38 | 2.120 |
Why?
| | Membrane Transport Proteins | 5 | 2023 | 138 | 2.040 |
Why?
| | Phagocytosis | 5 | 2015 | 349 | 1.730 |
Why?
| | Bacterial Proteins | 12 | 2023 | 735 | 1.710 |
Why?
| | Gram-Negative Bacteria | 3 | 2022 | 66 | 1.680 |
Why?
| | Microbiology | 10 | 2020 | 18 | 1.640 |
Why?
| | Iron | 3 | 2017 | 232 | 1.340 |
Why?
| | Periodicals as Topic | 11 | 2020 | 180 | 1.300 |
Why?
| | Microbial Sensitivity Tests | 5 | 2023 | 300 | 1.180 |
Why?
| | Virulence Factors | 4 | 2016 | 139 | 1.020 |
Why?
| | Cation Transport Proteins | 4 | 2016 | 123 | 1.010 |
Why?
| | Mice | 25 | 2023 | 14843 | 0.980 |
Why?
| | Bacterial Outer Membrane Proteins | 2 | 2022 | 58 | 0.980 |
Why?
| | Immunity, Innate | 2 | 2020 | 720 | 0.950 |
Why?
| | Host-Pathogen Interactions | 3 | 2020 | 295 | 0.870 |
Why?
| | Cell Membrane | 3 | 2022 | 670 | 0.860 |
Why?
| | Gene Expression Regulation, Bacterial | 6 | 2015 | 285 | 0.840 |
Why?
| | Animals | 31 | 2023 | 31565 | 0.840 |
Why?
| | Cardiolipins | 1 | 2022 | 70 | 0.790 |
Why?
| | Typhoid Fever | 2 | 2012 | 9 | 0.750 |
Why?
| | Capecitabine | 1 | 2021 | 45 | 0.750 |
Why?
| | Staphylococcus | 1 | 2021 | 69 | 0.750 |
Why?
| | Societies, Scientific | 5 | 2020 | 47 | 0.740 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2020 | 36 | 0.710 |
Why?
| | Fluorouracil | 1 | 2021 | 152 | 0.710 |
Why?
| | Erythrocytes | 2 | 2015 | 568 | 0.710 |
Why?
| | Staphylococcal Infections | 2 | 2021 | 340 | 0.700 |
Why?
| | Drug Resistance, Multiple, Bacterial | 4 | 2021 | 61 | 0.700 |
Why?
| | Clofazimine | 1 | 2020 | 14 | 0.690 |
Why?
| | Siderophores | 2 | 2017 | 9 | 0.680 |
Why?
| | Biofilms | 2 | 2021 | 223 | 0.670 |
Why?
| | Racism | 5 | 2020 | 99 | 0.650 |
Why?
| | Salmonella | 3 | 2017 | 54 | 0.630 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 167 | 0.620 |
Why?
| | Dipeptides | 1 | 2018 | 47 | 0.600 |
Why?
| | Bacterial Load | 1 | 2018 | 58 | 0.600 |
Why?
| | Disease Models, Animal | 6 | 2013 | 3498 | 0.600 |
Why?
| | Small Molecule Libraries | 1 | 2018 | 79 | 0.580 |
Why?
| | Lipid Metabolism | 1 | 2019 | 441 | 0.550 |
Why?
| | High-Throughput Screening Assays | 1 | 2018 | 123 | 0.550 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2009 | 75 | 0.520 |
Why?
| | Escherichia coli Proteins | 2 | 2015 | 162 | 0.520 |
Why?
| | Drug Tolerance | 1 | 2015 | 77 | 0.500 |
Why?
| | Bacterial Toxins | 1 | 2015 | 103 | 0.490 |
Why?
| | Antibodies | 1 | 2017 | 365 | 0.480 |
Why?
| | Cells | 1 | 2015 | 22 | 0.480 |
Why?
| | Oxides | 1 | 2015 | 40 | 0.470 |
Why?
| | Spleen | 5 | 2015 | 485 | 0.460 |
Why?
| | Metal Nanoparticles | 1 | 2015 | 69 | 0.450 |
Why?
| | Anemia | 1 | 2015 | 143 | 0.440 |
Why?
| | Enterobactin | 1 | 2013 | 6 | 0.440 |
Why?
| | Leukocytes | 1 | 2014 | 272 | 0.430 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 285 | 0.420 |
Why?
| | Virulence | 3 | 2023 | 228 | 0.420 |
Why?
| | Drug Resistance, Bacterial | 3 | 2017 | 156 | 0.390 |
Why?
| | Trehalose | 1 | 2012 | 30 | 0.390 |
Why?
| | Betaine | 1 | 2012 | 63 | 0.390 |
Why?
| | Salmonella typhi | 3 | 2010 | 11 | 0.380 |
Why?
| | Adaptive Immunity | 1 | 2013 | 154 | 0.380 |
Why?
| | Escherichia coli | 4 | 2022 | 723 | 0.370 |
Why?
| | Bacteria | 3 | 2023 | 725 | 0.370 |
Why?
| | Mammals | 2 | 2022 | 241 | 0.360 |
Why?
| | Porins | 2 | 2009 | 12 | 0.350 |
Why?
| | Lymphohistiocytosis, Hemophagocytic | 1 | 2010 | 28 | 0.340 |
Why?
| | Periplasm | 1 | 2009 | 10 | 0.340 |
Why?
| | Biological Transport | 2 | 2022 | 374 | 0.320 |
Why?
| | Genes, Bacterial | 2 | 2010 | 157 | 0.320 |
Why?
| | Transcription Factors | 4 | 2006 | 1526 | 0.320 |
Why?
| | Lipopolysaccharides | 3 | 2022 | 813 | 0.320 |
Why?
| | Stress, Physiological | 1 | 2012 | 379 | 0.320 |
Why?
| | Cells, Cultured | 5 | 2020 | 3861 | 0.300 |
Why?
| | Liver | 5 | 2014 | 1633 | 0.290 |
Why?
| | Macrophage Activation | 1 | 2008 | 163 | 0.280 |
Why?
| | Microbial Viability | 3 | 2019 | 79 | 0.280 |
Why?
| | Multienzyme Complexes | 2 | 2006 | 64 | 0.280 |
Why?
| | Phosphoprotein Phosphatases | 2 | 2006 | 64 | 0.280 |
Why?
| | Protein Kinases | 3 | 2006 | 304 | 0.270 |
Why?
| | Interferon-gamma | 3 | 2015 | 719 | 0.250 |
Why?
| | Cell Line | 4 | 2015 | 2629 | 0.250 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2003 | 742 | 0.250 |
Why?
| | Trans-Activators | 2 | 2005 | 366 | 0.240 |
Why?
| | Inflammation | 2 | 2012 | 2464 | 0.240 |
Why?
| | Monocytes | 2 | 2018 | 503 | 0.230 |
Why?
| | Multigene Family | 1 | 2005 | 190 | 0.230 |
Why?
| | Mice, Inbred Strains | 3 | 2010 | 398 | 0.210 |
Why?
| | Cryoelectron Microscopy | 1 | 2023 | 142 | 0.210 |
Why?
| | Glycerophospholipids | 1 | 2022 | 26 | 0.200 |
Why?
| | Phagosomes | 1 | 2022 | 38 | 0.200 |
Why?
| | Amines | 1 | 2022 | 34 | 0.200 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 1144 | 0.200 |
Why?
| | Humans | 25 | 2023 | 114045 | 0.190 |
Why?
| | Administration, Oral | 2 | 2021 | 725 | 0.190 |
Why?
| | Gram-Positive Bacteria | 1 | 2021 | 45 | 0.190 |
Why?
| | Liposomes | 1 | 2022 | 146 | 0.190 |
Why?
| | Gene Deletion | 2 | 2013 | 356 | 0.180 |
Why?
| | Prodrugs | 1 | 2021 | 42 | 0.180 |
Why?
| | DNA-Binding Proteins | 2 | 2005 | 1311 | 0.180 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 4680 | 0.170 |
Why?
| | Membrane Lipids | 1 | 2020 | 87 | 0.170 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 41 | 0.170 |
Why?
| | Cell Death | 1 | 2001 | 322 | 0.170 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 192 | 0.160 |
Why?
| | Flow Cytometry | 2 | 2013 | 1075 | 0.160 |
Why?
| | Drug Discovery | 1 | 2020 | 123 | 0.160 |
Why?
| | Polymyxin B | 2 | 2009 | 20 | 0.150 |
Why?
| | Staphylococcus aureus | 1 | 2021 | 385 | 0.150 |
Why?
| | Research | 1 | 2020 | 389 | 0.140 |
Why?
| | Cholera Toxin | 1 | 2017 | 27 | 0.140 |
Why?
| | Cell Separation | 1 | 2018 | 290 | 0.140 |
Why?
| | Microscopy | 1 | 2018 | 125 | 0.140 |
Why?
| | Superoxides | 1 | 2017 | 190 | 0.140 |
Why?
| | Mutation | 4 | 2014 | 3338 | 0.140 |
Why?
| | Vacuoles | 1 | 2016 | 33 | 0.130 |
Why?
| | Amino Acids | 1 | 2019 | 445 | 0.130 |
Why?
| | Mycobacterium marinum | 1 | 2015 | 2 | 0.130 |
Why?
| | Teichoic Acids | 1 | 2015 | 12 | 0.130 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 341 | 0.130 |
Why?
| | Toll-Like Receptor 9 | 1 | 2015 | 30 | 0.130 |
Why?
| | Meningitis | 1 | 2016 | 74 | 0.130 |
Why?
| | Adjuvants, Immunologic | 1 | 2017 | 206 | 0.130 |
Why?
| | 3T3 Cells | 1 | 2015 | 140 | 0.120 |
Why?
| | Bacillus subtilis | 1 | 2015 | 58 | 0.120 |
Why?
| | Mice, Inbred C3H | 1 | 2015 | 242 | 0.120 |
Why?
| | Female | 8 | 2021 | 59324 | 0.120 |
Why?
| | Toll-Like Receptor 2 | 1 | 2015 | 110 | 0.120 |
Why?
| | Duodenum | 1 | 2015 | 62 | 0.120 |
Why?
| | Glucose | 1 | 2019 | 899 | 0.120 |
Why?
| | Gastrointestinal Tract | 1 | 2017 | 169 | 0.120 |
Why?
| | Immunization | 1 | 2017 | 397 | 0.120 |
Why?
| | Species Specificity | 2 | 2013 | 541 | 0.110 |
Why?
| | Base Sequence | 3 | 2006 | 2114 | 0.110 |
Why?
| | Yersinia pseudotuberculosis Infections | 1 | 2012 | 1 | 0.100 |
Why?
| | Yersinia pseudotuberculosis | 1 | 2012 | 3 | 0.100 |
Why?
| | Cell Movement | 1 | 2016 | 863 | 0.100 |
Why?
| | RNA, Messenger | 2 | 2015 | 2550 | 0.100 |
Why?
| | Molecular Sequence Data | 3 | 2006 | 2783 | 0.100 |
Why?
| | Salinity | 1 | 2012 | 18 | 0.100 |
Why?
| | Salts | 1 | 2012 | 36 | 0.100 |
Why?
| | Chemokines | 1 | 2013 | 215 | 0.100 |
Why?
| | NF-kappa B | 1 | 2015 | 636 | 0.100 |
Why?
| | Immunophenotyping | 1 | 2012 | 274 | 0.090 |
Why?
| | Mutation, Missense | 1 | 2013 | 294 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2016 | 946 | 0.090 |
Why?
| | Mice, Knockout | 2 | 2015 | 2562 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 507 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 502 | 0.090 |
Why?
| | Genomic Islands | 1 | 2010 | 7 | 0.090 |
Why?
| | Cytoplasmic Vesicles | 1 | 2010 | 12 | 0.090 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 288 | 0.090 |
Why?
| | Splenomegaly | 1 | 2010 | 16 | 0.090 |
Why?
| | Bone Marrow Diseases | 1 | 2010 | 18 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1218 | 0.090 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 134 | 0.080 |
Why?
| | Ferritins | 1 | 2010 | 52 | 0.080 |
Why?
| | Dendritic Cells | 1 | 2013 | 435 | 0.080 |
Why?
| | Editorial Policies | 2 | 2020 | 44 | 0.080 |
Why?
| | Cathelicidins | 1 | 2009 | 38 | 0.080 |
Why?
| | Chromatography, Affinity | 1 | 2009 | 80 | 0.080 |
Why?
| | Immunoprecipitation | 1 | 2009 | 151 | 0.080 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 134 | 0.080 |
Why?
| | Apoptosis | 2 | 2012 | 2349 | 0.080 |
Why?
| | Immunoblotting | 1 | 2009 | 282 | 0.080 |
Why?
| | Fever | 1 | 2010 | 280 | 0.080 |
Why?
| | Thrombocytopenia | 1 | 2010 | 177 | 0.070 |
Why?
| | Carrier State | 1 | 2008 | 54 | 0.070 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1518 | 0.070 |
Why?
| | Jurkat Cells | 1 | 2007 | 128 | 0.070 |
Why?
| | Gammaproteobacteria | 1 | 2007 | 13 | 0.070 |
Why?
| | Phosphotransferases | 1 | 2006 | 25 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 990 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2007 | 266 | 0.070 |
Why?
| | Sigma Factor | 1 | 2006 | 33 | 0.070 |
Why?
| | Adenosine Monophosphate | 1 | 2006 | 49 | 0.070 |
Why?
| | Phylogeny | 2 | 2007 | 787 | 0.070 |
Why?
| | Cytokines | 1 | 2013 | 1824 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2010 | 817 | 0.060 |
Why?
| | Healthcare Disparities | 2 | 2020 | 479 | 0.060 |
Why?
| | Amino Acid Motifs | 1 | 2005 | 197 | 0.060 |
Why?
| | Sequence Alignment | 1 | 2005 | 323 | 0.060 |
Why?
| | Biomedical Research | 2 | 2020 | 582 | 0.060 |
Why?
| | United States | 4 | 2020 | 12137 | 0.060 |
Why?
| | Protein Binding | 1 | 2009 | 1888 | 0.060 |
Why?
| | Molecular Chaperones | 1 | 2005 | 156 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1577 | 0.060 |
Why?
| | Time Factors | 2 | 2012 | 6077 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2005 | 1131 | 0.050 |
Why?
| | Bacterial Capsules | 1 | 2003 | 28 | 0.050 |
Why?
| | Computational Biology | 1 | 2007 | 528 | 0.050 |
Why?
| | Down-Regulation | 1 | 2005 | 594 | 0.050 |
Why?
| | Genome, Bacterial | 1 | 2003 | 106 | 0.050 |
Why?
| | Male | 3 | 2020 | 55396 | 0.050 |
Why?
| | Genes, cdc | 1 | 2001 | 10 | 0.050 |
Why?
| | Caspase 1 | 1 | 2001 | 140 | 0.050 |
Why?
| | Blotting, Northern | 1 | 2001 | 193 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2001 | 255 | 0.040 |
Why?
| | Laboratory Personnel | 1 | 2020 | 3 | 0.040 |
Why?
| | Bias | 1 | 2020 | 178 | 0.040 |
Why?
| | Survival Rate | 1 | 2003 | 1638 | 0.040 |
Why?
| | Publishing | 1 | 2020 | 123 | 0.040 |
Why?
| | RNA, Bacterial | 1 | 2000 | 174 | 0.040 |
Why?
| | Communicable Diseases | 1 | 2020 | 127 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2020 | 200 | 0.040 |
Why?
| | DNA, Fungal | 1 | 1997 | 69 | 0.040 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 1997 | 59 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1997 | 119 | 0.030 |
Why?
| | Ataxia | 1 | 2016 | 35 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 2016 | 47 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2016 | 111 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2016 | 94 | 0.030 |
Why?
| | DNA Replication | 1 | 1997 | 202 | 0.030 |
Why?
| | Optical Imaging | 1 | 2016 | 52 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2001 | 1016 | 0.030 |
Why?
| | Encephalitis | 1 | 2016 | 126 | 0.030 |
Why?
| | Intestines | 1 | 2018 | 325 | 0.030 |
Why?
| | Bacteremia | 1 | 2016 | 160 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 186 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1997 | 333 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2017 | 268 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 917 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 1997 | 476 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 1997 | 549 | 0.030 |
Why?
| | Nanoparticles | 1 | 2017 | 312 | 0.030 |
Why?
| | Signal Transduction | 1 | 2006 | 4501 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1997 | 694 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 1997 | 591 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1624 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 684 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2018 | 1696 | 0.020 |
Why?
| | Shigella flexneri | 1 | 2007 | 11 | 0.020 |
Why?
| | Databases, Protein | 1 | 2007 | 59 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2007 | 126 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2007 | 101 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2007 | 452 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2355 | 0.020 |
Why?
| | Models, Genetic | 1 | 2007 | 559 | 0.010 |
Why?
| | Models, Statistical | 1 | 2007 | 595 | 0.010 |
Why?
| | Serotyping | 1 | 2003 | 28 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 2003 | 187 | 0.010 |
Why?
| | U937 Cells | 1 | 2001 | 22 | 0.010 |
Why?
| | Interleukin-18 | 1 | 2001 | 217 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 771 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1611 | 0.010 |
Why?
| | Algorithms | 1 | 2007 | 1469 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 2000 | 157 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2000 | 312 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2003 | 1690 | 0.010 |
Why?
| | Interleukin-1 | 1 | 2001 | 965 | 0.010 |
Why?
| | Cell Cycle | 1 | 1997 | 541 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2000 | 1310 | 0.010 |
Why?
|
|
Detweiler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|